Question 1

What is the catalog number for Compound NP-018252?

Accepted Answer

The catalog number for Compound NP-018252 is T126425.

Question 2

Is Compound NP-018252 in stock?

Accepted Answer

Compound NP-018252 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Who manufactures Compound NP-018252?

Accepted Answer

Compound NP-018252 is manufactured by Molfinity.

Question 4

What is the estimated delivery time for Compound NP-018252?

Accepted Answer

Estimated delivery time for Compound NP-018252 is approximately 10 business day(s), depending on your location.

Question 5

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Question 6

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 7

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Compound NP-018252

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

Anti-Liver Carboxylesterase 1/CES1 Antibody Picoband® (Dylight594 Conjugate)

AdmiRa-hsa-miR-526b-3p-Off Virus

Rat SOCS3 ELISA Kit

Rat SOCS3 ELISA Kit

Anti-human IL-17Ra / CD217 (Brodalumab Biosimilar)

Anti-human IL-17Ra / CD217 (Brodalumab Biosimilar)